Protara Therapeutics, Inc. · NASDAQ:TARA
Janus Henderson Group PLC reported a 10.50% stake in Protara Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
Janus Henderson Group PLC reported a 10.50% stake in Protara Therapeutics, Inc., 3,862,551 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 10.50%
- Shares
- 3,862,551
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 10.50% | 3,862,551 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.10% | 3,356,076 |
Source
Related
- Protara Therapeutics, Inc.
- Janus Henderson Group PLC
- Protara Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Nov 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Millennium Management LLC · Jul 7, 2026
- Form 4 · Shefferman Jesse · Jul 1, 2026
- Form 4 · Conkling William · Jun 3, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Form 4 · Zummo Jacqueline · Apr 9, 2026